To investigate the association of cognitive impairment (COGI) and depression with all-cause mortality and cardiovascular-specific mortality among community-dwelling elderly individuals in rural Greece.
Methods:
Cognition and depressive symptomatology of 676 Velestino town residents aged ≥60 years were assessed using Mini-Mental State Examination (MMSE) and Geriatric Depression Scale (GDS), respectively. Eight-year all-cause mortality and cardiovascular mortality were explored by multivariate Cox regression models controlling for major confounders.
Results:
Two hundred and one patients died during follow-up. Cognitive impairment (MMSE ≤ 23) was independently associated with all-cause mortality (hazard ratio [HR]: 1.57, 95% confidence interval [CI]: 1.13-2.18) and cardiovascular mortality (HR: 1.57, 95%CI: 1.03-2.41). Moderate to severe depression (GDS > 10) was significantly associated only with a 51% increase in all-cause mortality. A male-specific association was noted for moderate to severe depression, whereas the effect of COGI was limited to females. Noteworthy, COGI and depression comorbidity, rather than their sole presence, increased all-cause mortality and cardiovascular mortality by 66% and 72%, respectively. The mortality effect of COGI was augmented among patients with depression and of depression among patients with COGI.
Conclusion:
COGI and depression, 2 entities often coexisting among elderly individuals, appear to increase all-cause mortality and cardiovascular mortality. Gender-specific modes may prevail but their comorbidity should be carefully assessed, as it seems to represent an independent index of increased frailty, which eventually shortens life expectancy.
SosaALAlbaneseEStephanBC. Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study. PLoS Med. 2012;9(2):e1001170.
3.
RaitGFletcherASmeethL. Prevalence of cognitive impairment: results from the MRC trial of assessment and management of older people in the community. Age Ageing. 2005;34(3):242–248.
4.
PrinceMBryceRAlbaneseEWimoARibeiroWFerriCP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75. e62.
5.
BaruaAGhoshMKKarNBasilioMA. Prevalence of depressive disorders in the elderly. Ann Saudi Med. 2011;31(6):620–624.
6.
PapadopoulosFCPetridouEArgyropoulouS. Prevalence and correlates of depression in late life: a population based study from a rural Greek town. Int J Geriatr Psychiatry. 2005;20(4):350–357.
7.
PlassmanBLLangaKMFisherGG. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med. 2008;148(6):427–434.
8.
GharacholouSMReidKJArnoldSV. Cognitive impairment and outcomes in older adult survivors of acute myocardial infarction: findings from the translational research investigating underlying disparities in acute myocardial infarction patients’ health status registry. Am Heart J. 2011;162(5):860–869. e861.
9.
WangZJGuoMSiTM. Association of depression with adverse cardiovascular events after percutaneous coronary intervention. Coron Artery Dis. 2013;24(7):589–595.
10.
WangSLPanWHLeeMCChengSPChangMC. Predictors of survival among elders suffering strokes in Taiwan: observation from a nationally representative sample. Stroke. 2000;31(10):2354–2360.
11.
GabaldonLFuentesBFrank-GarciaADiez-TejedorE. Poststroke depression: importance of its detection and treatment. Cerebrovasc Dis. 2007;24(suppl 1):181–188.
12.
ParkMHKwonDYJungJMHanCJoIJoSA. Mini-Mental Status Examination as predictors of mortality in the elderly. Acta Psychiatr Scand. 2013;127(4):298–304.
13.
BassukSSWypijDBerkmanLF. Cognitive impairment and mortality in the community-dwelling elderly. Am J Epidemiol. 2000;151(7):676–688.
14.
Saint OngeJMKruegerPMRogersRG. The relationship between major depression and nonsuicide mortality for U.S. adults: the importance of health behaviors. J Gerontol B Psychol Sci Soc Sci. 2014;69(4):622–632.
15.
HouleJN. Depressive symptoms and all-cause mortality in a nationally representative longitudinal study with time-varying covariates. Psychosom Med. 2013;75(3):297–304.
16.
KatsoulisMKyrozisATrichopoulouABamiaCTrichopoulosDLagiouP. Cognitive impairment and cancer mortality: a biological or health care explanation?Cancer Causes Control. 2014;25(11):1565–1570.
17.
SunWJXuLChanWMLamTHSchoolingCM. Are depressive symptoms associated with cardiovascular mortality among older Chinese: a cohort study of 64,000 people in Hong Kong?Am J Geriatr Psychiatry. 2013;21(11):1107–1115.
18.
PanzaFFrisardiVCapursoC. Late-life depression, mild cognitive impairment, and dementia: possible continuum?Am J Geriatr Psychiatry. 2010;18(2):98–116.
19.
MehtaKMYaffeKLangaKMSandsLWhooleyMACovinskyKE. Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults. J Gerontol A Biol Sci Med Sci. 2003;58(5):M461–M467.
20.
ColeMGDendukuriN. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry. 2003;160(6):1147–1156.
21.
WuCYChouYCHuangNChouYJHuHYLiCP. Cognitive impairment assessed at annual geriatric health examinations predicts mortality among the elderly. Prev Med. 2014;67:28–34.
22.
PernaLWahlHWMonsUSaumKUHolleczekBBrennerH. Cognitive impairment, all-cause and cause-specific mortality among non-demented older adults. Age Ageing. 2015;44(3):445–451.
23.
MichelakosTKousoulisAAKatsiardanisK. Serum folate and B12 levels in association with cognitive impairment among seniors: results from the VELESTINO study in Greece and meta-analysis. J Aging Health. 2013;25(4):589–616.
24.
ManciaGFagardRNarkiewiczK. 2013ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–1357.
25.
JellingerPSSmithDAMehtaAE. American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr Pract. 2012;18(suppl 1):1–78.
26.
American DiabetesA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(suppl 1):S81–S90.
27.
FountoulakisKNTsolakiMIacovidesA. The validation of the short form of the Geriatric Depression Scale (GDS) in Greece. Aging (Milano). 1999;11(6):367–372.
28.
FountoulakisKTsolakiMChantziHKazisA. Mini-Mental State Examination (MMSE): a validation study in Greece. Am J Alzheimers Dis Other Demen. 2000;15(6):342–345.
29.
Schultz-LarsenKRahmanfardNKreinerSAvlundKHolstC. Cognitive impairment as assessed by a short form of MMSE was predictive of mortality. J Clin Epidemiol. 2008;61(12):1227–1233.
30.
MengXD’ArcyC. Mortality and morbidity hazards associated with cognitive status in seniors: a Canadian population prospective cohort study. Asia Pac Psychiatry. 2013;5(3):175–182.
31.
O’DonnellMTeoKGaoP. Cognitive impairment and risk of cardiovascular events and mortality. Eur Heart J. 2012;33(14):1777–1786.
32.
BosworthHBSchaieKWWillisSL. Cognitive and sociodemographic risk factors for mortality in the Seattle Longitudinal Study. J Gerontol B Psychol Sci Soc Sci. 1999;54(5): P273–P282.
33.
NguyenHTBlackSARayLAEspinoDVMarkidesKS. Cognitive impairment and mortality in older mexican americans. J Am Geriatr Soc. 2003;51(2):178–183.
34.
DeweyMESazP. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry. 2001;16(8):751–761.
35.
GuehneUAngermeyerMCRiedel-HellerS. Is mortality increased in mildly cognitively impaired individuals? A systematic literature review. Dement Geriatr Cogn Disord. 2006;21(5-6):403–410.
36.
de la TorreJC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 2002;33(4):1152–1162.
37.
CarterCJ.Convergence of genes implicated in Alzheimer’s disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis. Neurochem Int. 2007;50(1):12–38.
38.
CasserlyITopolE. Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet. 2004;363(9415):1139–1146.
39.
LatheRSapronovaAKotelevtsevY. Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature. BMC Geriatr. 2014;14:36.
40.
KelleherRJSoizaRL. Evidence of endothelial dysfunction in the development of Alzheimer’s disease: is Alzheimer’s a vascular disorder?Am J Cardiovasc Dis. 2013;3(4):197–226.
41.
TengPRYehCJLeeMCLinHSLaiTJ. Depressive symptoms as an independent risk factor for mortality in elderly persons: results of a national longitudinal study. Aging Ment Health. 2013;17(4):470–478.
42.
JotheeswaranATWilliamsJDPrinceMJ. Predictors of mortality among elderly people living in a south Indian urban community; a 10/66 Dementia Research Group prospective population-based cohort study. BMC Public Health. 2010;10:366.
43.
DinizBSReynoldsCFIIIButtersMA. The effect of gender, age, and symptom severity in late-life depression on the risk of all-cause mortality: the Bambui Cohort Study of Aging. Depress Anxiety. 2014;31(9):787–795.
44.
SchulzRBeachSRIvesDGMartireLMAriyoAAKopWJ. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med. 6262000;160(12):1761–1768.
45.
WadaTKasaharaYMatsubayashiK. Fifteen-item geriatric depression scale predicts 8-year mortality in older Japanese. J Am Geriatr Soc. 2011;59(11):2159–2160.
46.
KohlerSVerheyFWeyererS. Depression, non-fatal stroke and all-cause mortality in old age: a prospective cohort study of primary care patients. J Affect Disord. 2013;150(1):63–69.
47.
SazPDeweyME. Depression, depressive symptoms and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry. 2001;16(6):622–630.
48.
RyanJCarriereIRitchieK. Late-life depression and mortality: influence of gender and antidepressant use. Br J Psychiatry. 2008;192(1):12–18.
49.
DinizBSTeixeiraALTalibLLMendoncaVAGattazWFForlenzaOV. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. J Psychiatr Res. 2010;44(14):917–920.
50.
Wium-AndersenMKOrstedDDNielsenSFNordestgaardBG. Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiatry. 2013;70(2):176–184.
51.
DimopoulosNPiperiCPsarraVLeaRWKalofoutisA. Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression. Psychiatry Res. 2008;161(1):59–66.
52.
PenninxBWBeekmanATBandinelliS. Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo-pituitary-adrenal axis. Am J Geriatr Psychiatry. 2007;15(6):522–529.
53.
WolkowitzOMMellonSHEpelES. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings. PLoS One. 2011;6(3):e17837.
54.
HiltunenMNieminenTKettunenR. Depressive symptoms and cardiovascular burden-related mortality among the aged. Eur J Clin Invest. 2014;44(5):486–492.
55.
AlexopoulosGSMeyersBSYoungRCCampbellSSilbersweigDCharlsonM. ‘Vascular depression’ hypothesis. Arch Gen Psychiatry. 1997;54(10):915–922.
56.
BouzinovaEVNorregaardRBoedtkjerDM. Association between endothelial dysfunction and depression-like symptoms in chronic mild stress model of depression. Psychosom Med. 2014;76(4):268–276.
57.
MusselmanDLMarzecUDavidoffM. Platelet activation and secretion in patients with major depression, thoracic aortic atherosclerosis, or renal dialysis treatment. Depress Anxiety. 2002;15(3):91–101.
58.
McCafferyJMFrasure-SmithNDubeMP. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med. 2006;68(2):187–200.
59.
LavretskyHZhengLWeinerMW. Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study. Am J Psychiatry. 2010;167(5):589–597.
60.
ArfkenCLLichtenbergPATancerME. Cognitive impairment and depression predict mortality in medically ill older adults. J Gerontol A Biol Sci Med Sci. 1999;54(3): M152–156.
61.
ButtersMAYoungJBLopezO. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci. 2008;10(3):345–357.
CuijpersPVogelzangsNTwiskJKleiboerALiJPenninxBW. Is excess mortality higher in depressed men than in depressed women? A meta-analytic comparison. J Affect Disord. 2014;161:47–54.
64.
PenninxBWGuralnikJMMendes de LeonCF. Cardiovascular events and mortality in newly and chronically depressed persons > 70 years of age. Am J Cardiol. 1998;81(8):988–994.
65.
KilanderLBerglundLBobergMVessbyBLithellH. Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men. Int J Epidemiol. 2001;30(5):1119–1126.
66.
BrehautJCRainaPLindsayJ. Does cognitive status modify the relationship between education and mortality? Evidence from the Canadian Study of Health and Aging. Int Psychogeriatr. 2004;16(1):75–91.
67.
GrippoAJGerenaDHuangJ. Social isolation induces behavioral and neuroendocrine disturbances relevant to depression in female and male prairie voles. Psychoneuroendocrinology. 2007;32(8-10):966–980.
68.
Emerging Risk FactorsCSeshasaiSRKaptogeS. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–841.
